We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
55 hedge funds and large institutions have $7.86M invested in Cardiff Oncology in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more call options, than puts
Call options by funds: $62K | Put options by funds: $48K
4% more capital invested
Capital invested by funds: $7.58M → $7.86M (+$275K)
0% more funds holding
Funds holding: 55 → 55 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0.17% less ownership
Funds ownership: 12.05% → 11.88% (-0.17%)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Holders
55
Holders Change
–
Holders Change %
0%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
13
Closed
7
Calls
$62K
Puts
$48K
Net Calls
+$14K
Net Calls Change
-$266K
Top Buyers
| 1 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$187K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$40.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$33.6K |
| 5 |
Jane Street
New York
|
+$26.2K |
